Generic placeholder image

Recent Patents on Nanotechnology

Editor-in-Chief

ISSN (Print): 1872-2105
ISSN (Online): 2212-4020

Research Article

Formulation and Characterization of Self-Microemulsifying Drug Delivery System (SMEDDS) of Sertraline Hydrochloride

Author(s): Sanjay Sharma, Abhishek Kanugo*, Tejvir Kaur and Deepak Choudhary*

Volume 18, Issue 1, 2024

Published on: 05 October, 2022

Page: [3 - 16] Pages: 14

DOI: 10.2174/1872210516666220623152440

Price: $65

Abstract

Background: Sertraline hydrochloride is the most widely used selective serotonin reuptake inhibitor (SSRI) for treating several depressive disorders. The applicability of Sertraline hydrochloride is limited due to the extensive metabolism and poor oral bioavailability of 44%.

Objective: The current research focused on improving the solubility and oral bioavailability of Sertraline in the form of microemulsion developed by a self-micro emulsifying drug delivery system (SMEDDS) for significant antidepressant action.

Methods: SMEDDS were developed by selecting appropriate proportions of oil, surfactant, and cosolvent, and out of them, isopropyl myristate, tween 80, and propylene glycol were selected. The emulsification zone was demonstrated by a ternary phase diagram, and the compatibility was confirmed with Fourier-transformed infrared spectroscopy (FT-IR). The formulated SMEDDS was characterized by the robustness to dilution, globule size (GS), polydispersity index (PDI), viscosity, in-vitro dissolution, diffusion study, and drug release kinetics study. The Patents US 9,770,509 B2, and US 2021/0236628 A1 were available for the SMEDDS.

Results: All the batches (A1-A9) passed the quality test, and A3 was selected as an optimized batch that doesn’t show phase separation and precipitation. The optimized batch A3 showed globule size (101 nm), PDI (0.319), drug content (99.14 ± 0.35%), viscosity (10.71 ± 0.02 mPa), self-emulsification time (46 sec), in-vitro drug release (98.25 ± 0.22%) within eight h, release kinetics (Higuchi), and the effective antidepressant action during in-vitro diffusion studies.

Conclusion: An optimized batch A3 was observed, which was circular in shape and estimated by Transmission electron microscopy (TEM), passing all the thermodynamic stability testing with a loss of 0.271 mg of the drug after 90 days, and showed marked antidepressant action with higher stability.

Keywords: Sertraline HCl, SMEDDS, Ternary phase diagram, Particle size, Higuchi model.

Graphical Abstract

[1]
Alayoubi A, Aqueel MS, Cruz CN, Ashraf M, Zidan AS. Application of in vitro lipolysis for the development of oral self-emulsified delivery system of nimodipine. Int J Pharm 2018; 553(1-2): 441-53.
[http://dx.doi.org/10.1016/j.ijpharm.2018.10.066] [PMID: 30385374]
[2]
Christiansen ML, Holm R, Kristensen J, et al. Cinnarizine food-effects in beagle dogs can be avoided by administration in a self nano emulsifying drug delivery system (SNEDDS). Eur J Pharm Sci 2014; 57: 164-72.
[http://dx.doi.org/10.1016/j.ejps.2013.11.003] [PMID: 24239996]
[3]
Custodio JM, Wu CY, Benet LZ. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Adv Drug Deliv Rev 2008; 60(6): 717-33.
[http://dx.doi.org/10.1016/j.addr.2007.08.043] [PMID: 18199522]
[4]
Breitkreitz MC, Sabin GP, Polla G, Poppi RJ. Characterization of semi-solid Self-Emulsifying Drug Delivery Systems (SEDDS) of atorvastatin calcium by Raman image spectroscopy and chemometrics. J Pharm Biomed Anal 2013; 73: 3-12.
[http://dx.doi.org/10.1016/j.jpba.2012.03.054] [PMID: 22522036]
[5]
Singh A, Worku ZA, Van den Mooter G. Oral formulation strategies to improve solubility of poorly water-soluble drugs. Expert Opin Drug Deliv 2011; 8(10): 1361-78.
[http://dx.doi.org/10.1517/17425247.2011.606808] [PMID: 21810062]
[6]
Mazzeti AL, Oliveira LT, Gonçalves KR, Schaun GC, Mosqueira VCF, Bahia MT. Benznidazole self-emulsifying delivery system: A novel alternative dosage form for Chagas disease treatment. Eur J Pharm Sci 2020; 145: 105234.
[http://dx.doi.org/10.1016/j.ejps.2020.105234] [PMID: 31978590]
[7]
Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies. Adv Drug Deliv Rev 2008; 60(6): 625-37.
[http://dx.doi.org/10.1016/j.addr.2007.10.010] [PMID: 18068260]
[8]
O’Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 2002; 15(5): 405-15.
[http://dx.doi.org/10.1016/S0928-0987(02)00051-9] [PMID: 12036717]
[9]
Zhao Y, Yu B, Yu G, Li W. Study on the water-heat coupled phenomena in thawing frozen soil around a buried oil pipeline. Appl Therm Eng 2014; 73(2): 1477-88.
[http://dx.doi.org/10.1016/j.applthermaleng.2014.06.017]
[10]
Atty SA, Ibrahim AH, Ibrahim H, Abdelzaher AM, Abdel-Raoof AM, Fouad FA. Simultaneous voltammetric detection of anti-depressant drug, sertraline HCl and paracetamol in biological fluid at CNT-cesium modified electrode in micellar media. Microchem J 2020; 159: 105524.
[http://dx.doi.org/10.1016/j.microc.2020.105524]
[11]
Abouhussein D, El Nabarawi MA, Shalaby SH, El-Bary AA. Sertraline-cyclodextrin complex orodispersible sublingual tablet: Optimization, stability, and pharmacokinetics. J Pharm Innov 2021; 16(1): 53-66.
[http://dx.doi.org/10.1007/s12247-019-09416-1]
[12]
Zupančič O, Partenhauser A, Lam HT, Rohrer J, Bernkop-Schnürch A. Development and in vitro characterisation of an oral self-emulsifying delivery system for daptomycin. Eur J Pharm Sci 2016; 81: 129-36.
[http://dx.doi.org/10.1016/j.ejps.2015.10.005] [PMID: 26485536]
[13]
Kazi M, Al-Swairi M, Ahmad A, et al. Evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for poorly water-soluble talinolol: Preparation, in vitro and in vivo assessment. Front Pharmacol 2019; 10: 459.
[http://dx.doi.org/10.3389/fphar.2019.00459] [PMID: 31118895]
[14]
Pandit A, Kedar A, Koyate K. Hollow pessary loaded with lawsone via self-microemulsifying drug delivery system for vaginal candidiasis. J Drug Deliv Sci Technol 2020; 60: 101955.
[http://dx.doi.org/10.1016/j.jddst.2020.101955]
[15]
Buya AB, Ucakar B, Beloqui A, Memvanga PB, Préat V. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDSs) for senicapoc. Int J Pharm 2020; 580: 119180.
[http://dx.doi.org/10.1016/j.ijpharm.2020.119180] [PMID: 32135227]
[16]
Patel D, Sawant KK. Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev Ind Pharm 2007; 33(12): 1318-26.
[http://dx.doi.org/10.1080/03639040701385527] [PMID: 18097805]
[17]
Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm 2007; 329(1-2): 166-72.
[http://dx.doi.org/10.1016/j.ijpharm.2006.08.038] [PMID: 17010543]
[18]
Sarheed O, Shouqair D, Ramesh KVRNS, et al. Formation of stable nanoemulsions by ultrasound-assisted two-step emulsification process for topical drug delivery: Effect of oil phase composition and surfactant concentration and loratadine as ripening inhibitor. Int J Pharm 2020; 576: 118952.
[http://dx.doi.org/10.1016/j.ijpharm.2019.118952] [PMID: 31843549]
[19]
AboulFotouh K. Allam AA, El-Badry M, El-Sayed AM. Development and in vitro/in vivo performance of self-nanoemulsifying drug deliv-ery systems loaded with candesartan cilexetil. Eur J Pharm Sci 2017; 109: 503-13.
[http://dx.doi.org/10.1016/j.ejps.2017.09.001] [PMID: 28889028]
[20]
Zhang N, Zhang F, Xu S, Yun K, Wu W, Pan W. Formulation and evaluation of luteolin supersaturatable self-nanoemulsifying drug delivery system (S-SNEDDS) for enhanced oral bioavailability. J Drug Deliv Sci Technol 2020; 58: 101783.
[http://dx.doi.org/10.1016/j.jddst.2020.101783]
[21]
Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm 2010; 391(1-2): 203-11.
[http://dx.doi.org/10.1016/j.ijpharm.2010.03.008] [PMID: 20214965]
[22]
Chen L, Liu CS, Chen QZ, et al. Characterization, pharmacokinetics and tissue distribution of chlorogenic acid-loaded self-microemulsifying drug delivery system. Eur J Pharm Sci 2017; 100: 102-8.
[http://dx.doi.org/10.1016/j.ejps.2017.01.011] [PMID: 28089660]
[23]
Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004; 58(3): 173-82.
[http://dx.doi.org/10.1016/j.biopha.2004.02.001] [PMID: 15082340]
[24]
Jo K, Kim H, Khadka P, et al. Enhanced intestinal lymphatic absorption of saquinavir through supersaturated self-microemulsifying drug delivery systems. Asian J Pharm Sci 2020; 15(3): 336-46.
[http://dx.doi.org/10.1016/j.ajps.2018.11.009] [PMID: 32636951]
[25]
Ćetković Z, Cvijić S, Vasiljević D. Formulation and characterization of novel lipid-based drug delivery systems containing polymethacrylate polymers as solid carriers for sustained release of simvastatin. J Drug Deliv Sci Technol 2019; 53: 101222.
[http://dx.doi.org/10.1016/j.jddst.2019.101222]
[26]
Liu J, Wang Q, Omari-Siaw E, et al. Enhanced oral bioavailability of bisdemethoxycurcumin-loaded self-microemulsifying drug delivery system: Formulation design, in vitro and in vivo evaluation. Int J Pharm 2020; 590: 119887.
[http://dx.doi.org/10.1016/j.ijpharm.2020.119887] [PMID: 32950666]
[27]
Balakumar K, Raghavan CV, Selvan NT, Rahman SH. Self emulsifying drug delivery system: Optimization and its prototype for various compositions of oils, surfactants and co-surfactants. J Pharm Res 2013; 6(5): 510-4.
[http://dx.doi.org/10.1016/j.jopr.2013.04.031]
[28]
Han H, Li Y, Peng Z, et al. A soluplus/poloxamer 407-based self-nanoemulsifying drug delivery system for the weakly basic drug carve-dilol to improve its bioavailability. Nanomedicine 2020; 27: 102199.
[http://dx.doi.org/10.1016/j.nano.2020.102199] [PMID: 32275957]
[29]
Pandey V, Kohli S. SMEDDS of pioglitazone: Formulation, in vitro evaluation and stability studies. Future J Pharm Sci 2017; 3(1): 53-9.
[http://dx.doi.org/10.1016/j.fjps.2017.02.003]
[30]
Jaiswal P, Aggarwal G, Harikumar SL, Singh K. Development of self-microemulsifying drug delivery system and solid-self-microemulsifying drug delivery system of telmisartan. Int J Pharm Investig 2014; 4(4): 195-206.
[http://dx.doi.org/10.4103/2230-973X.143123] [PMID: 25426441]
[31]
Qureshi MJ, Mallikarjun C, Kian WG. Enhancement of solubility and therapeutic potential of poorly soluble lovastatin by SMEDDS formulation adsorbed on directly compressed spray dried magnesium aluminometasilicate liquid loadable tablets: A study in diet induced hyperlipidemic rabbits. Asian journal of pharmaceutical. Sciences (New York) 2015; 10(1): 40-56.
[32]
Elsheikh MA, Elnaggar YS, Gohar EY, Abdallah OY. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: Optimization and in vivo appraisal. Int J Nanomedicine 2012; 7: 3787-802.
[PMID: 22888234]
[33]
Qian J, Meng H, Xin L, et al. Self-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and in vitro and in vivo evaluation. Colloids Surf B Biointerfaces 2017; 160: 101-9.
[http://dx.doi.org/10.1016/j.colsurfb.2017.09.020] [PMID: 28917148]
[34]
Palamakula A, Khan MA. Evaluation of cytotoxicity of oils used in coenzyme Q10 Self-emulsifying Drug Delivery Systems (SEDDS). Int J Pharm 2004; 273(1-2): 63-73.
[http://dx.doi.org/10.1016/j.ijpharm.2003.12.010] [PMID: 15010131]
[35]
Parmar N, Singla N, Amin S, Kohli K. Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system. Colloids Surf B Biointerfaces 2011; 86(2): 327-38.
[http://dx.doi.org/10.1016/j.colsurfb.2011.04.016] [PMID: 21550214]
[36]
Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm 2008; 355(1-2): 269-76.
[http://dx.doi.org/10.1016/j.ijpharm.2007.12.026] [PMID: 18242895]
[37]
Crawford B, Kasmidi M, Korompis F, Pollnac RB. Factors influencing progress in establishing community-based marine protected areas in Indonesia. Coast Manage 2006; 34(1): 39-64.
[http://dx.doi.org/10.1080/08920750500379300]
[38]
Rajesh SY, Singh SK, Pandey NK, et al. Impact of various solid carriers and spray drying on pre/post compression properties of solid SNEDDS loaded with glimepiride: In vitro-ex vivo evaluation and cytotoxicity assessment. Drug Dev Ind Pharm 2018; 44(7): 1056-69.
[http://dx.doi.org/10.1080/03639045.2018.1431656] [PMID: 29360412]
[39]
Li L, Zhou CH, Xu ZP. Self-nanoemulsifying drug-delivery system and solidified self-nanoemulsifying drug-delivery system. In: Nanocarriers for Drug Delivery. Elsevier: Asterdam Netherland 2019; p. 421-49.
[http://dx.doi.org/10.1016/B978-0-12-814033-8.00014-X]
[40]
Baheti A, Srivastava S, Sahoo D, et al. Development and pharmacokinetic evaluation of industrially viable self-microemulsifying drug delivery systems (SMEDDS) for terbinafine. Curr Drug Deliv 2015; 13(1): 65-75.
[http://dx.doi.org/10.2174/1567201812666150120153357] [PMID: 25600982]
[41]
Buyukozturk F, Benneyan JC, Carrier RL. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. J Control Release 2010; 142(1): 22-30.
[http://dx.doi.org/10.1016/j.jconrel.2009.10.005] [PMID: 19850092]
[42]
Balakumar K, Raghavan CV. selvan NT, prasad RH, Abdu S. Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: Design, formulation, bioavailability and pharmacokinetic evaluation. Colloids Surf B Biointerfaces 2013; 112: 337-43.
[http://dx.doi.org/10.1016/j.colsurfb.2013.08.025] [PMID: 24012665]
[43]
Balakrishnan P, Lee BJ, Oh DH, et al. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm 2009; 72(3): 539-45.
[http://dx.doi.org/10.1016/j.ejpb.2009.03.001] [PMID: 19298857]
[44]
Bandyopadhyay S, Katare OP, Singh B. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B Biointerfaces 2012; 100: 50-61.
[http://dx.doi.org/10.1016/j.colsurfb.2012.05.019] [PMID: 22766282]
[45]
Negi LM, Tariq M, Talegaonkar S. Nano scale self-emulsifying oil based carrier system for improved oral bioavailability of camptothecin derivative by P-Glycoprotein modulation. Colloids Surf B Biointerfaces 2013; 111: 346-53.
[http://dx.doi.org/10.1016/j.colsurfb.2013.06.001] [PMID: 23850745]
[46]
Khoo SM, Humberstone AJ, Porter CJ, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm 1998; 167(1-2): 155-64.
[http://dx.doi.org/10.1016/S0378-5173(98)00054-4]
[47]
Jansen KMB, Agterof WGM, Mellema J. Viscosity of surfactant stabilized emulsions. J Rheol (NYNY) 2001; 45(6): 1359-71.
[http://dx.doi.org/10.1122/1.1410372]
[48]
Parikh KJ, Sawant KK. Solubilization of vardenafil HCl in lipid-based formulations enhances its oral bioavailability in vivo: A comparative study using Tween-20 and Cremophor-EL. J Mol Liq 2019; 277: 189-99.
[http://dx.doi.org/10.1016/j.molliq.2018.12.079]
[49]
Nandi I. Self-emulsifying solid oral dosage forms of allergen and their preparation thereof. US Patent 2021/0236628 A1, 2021.
[50]
Hassan E. Self-micro emulsifying drug delivery system with increased bioavailability. US Patent 9, 770, 509 B2, 2017.
[51]
Rahman MA, Iqbal Z, Hussain A. Formulation optimization and in vitro characterization of sertraline loaded self-nanoemulsifying drug delivery system (SNEDDS) for oral administration. J Pharm Investig 2012; 42(4): 191-202.
[http://dx.doi.org/10.1007/s40005-012-0029-0]
[52]
Agrawal AG, Kumar A, Gide PS. Self emulsifying drug delivery system for enhanced solubility and dissolution of glipizide. Colloids Surf B Biointerfaces 2015; 126: 553-60.
[http://dx.doi.org/10.1016/j.colsurfb.2014.11.022] [PMID: 25576032]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy